US 11325938
CD73 inhibitors
granted A61KA61K45/06A61P
Quick answer
US patent 11325938 (CD73 inhibitors) held by ORIC PHARMACEUTICALS, INC. expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ORIC PHARMACEUTICALS, INC.
- Grant date
- Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K45/06, A61P, A61P25/28